Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

iwCLL 2019 | What role could genomics play in oncology?

Richard Rosenquist • 21 Sep 2019
iwCLL 2019
Chronic Lymphocytic Leukemia Leukemia

Richard Rosenquist, MD, PhD, Karolinska University Hospital, Solna, Sweden, elaborates on the role of genome sequencing in prognostics and suggests the utility of whole-genome sequencing in the oncological field. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

More from Richard Rosenquist

The advancements and remaining challenges in precision medicine for CLL 2:09
The advancements and remaining challenges in precision medicine for CLL
Richard Rosenquist • 27 Sep 2024
Recommendations for biomarker analysis in CLL: updates from ERIC 2024 5:40
Recommendations for biomarker analysis in CLL: updates from ERIC 2024
Richard Rosenquist • 27 Sep 2024
The impact of IGHV mutational status in treatment decisions in CLL 1:50
The impact of IGHV mutational status in treatment decisions in CLL
Richard Rosenquist • 7 Oct 2022
Common genetic tests in CLL & when these tests should be performed 1:26
Common genetic tests in CLL & when these tests should be performed
Richard Rosenquist • 7 Oct 2022

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals